Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Oct 09, 2024 12:04pm
144 Views
Post# 36259483

RE:RE:RE:small trades

RE:RE:RE:small trades

I see shorting as a short term price control tactic, useful only in particular ways for a thinly traded off-the-radar Cdn microcap stock. Doesn't take many shares ( up to 2m or so = less than 1% of float) add a couple of cooperative brokerage houses, a few FUD workers and maybe a Market Maker and Bob's your uncle. 

Once volume returns ( expected in the months leading up to Top Line data release which is at least 30-60 days after last patient is enrolled) , history shows that it would be a dangerous strategy to hold a significant short position . 

Who needs to control or tweak the SP in the short-term? That's a matter of speculation. I don't see it as a particularly risky venture during the period of calm before the storm. LT retailers have to decide if it makes sense to join'em vs trying to lick'em. Not by shorting themselves, but rather taking advantage of the short-term discount. Most LT retail holders, however, feel that they are full up as it is. Would be shorters know this and as such are often able to work it down fairly easily. 

Makes no difference to the final outcome except slightly higher dilution coming from any last minute financings ( my biggest problem with under promotion) 

MM 

 

<< Previous
Bullboard Posts
Next >>